World's Best Scientists 2026 revealed!
VIEW LIST
Howard L. Kaufman

Howard L. Kaufman

Harvard University
United States

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 85 1301 1185 676 603 411 34317
Medicine 85 14423 13580 7297 6753 417 34572

Howard L. Kaufman publications per year

The chart shows the history of publications by Howard L. Kaufman between 1991 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Howard L. Kaufman published across 35 years, from 1991 to 2025, averaging 14.5 papers a year. Output peaked at 46 publications in 2016. 55 of the 506 publications appeared in the last two years.

No. of publications
10 20 30 40
Bar chart. Horizontal axis: year, 1991 to 2025. Vertical axis: number of publications, 0 to 46. Peak 46 publications in 2016. 1991: 1 publication 1992: 2 publications 1993: 2 publications 1994: 0 publications 1995: 0 publications 1996: 4 publications 1997: 1 publication 1998: 2 publications 1999: 3 publications 2000: 8 publications 2001: 5 publications 2002: 9 publications 2003: 8 publications 2004: 20 publications 2005: 13 publications 2006: 14 publications 2007: 13 publications 2008: 10 publications 2009: 8 publications 2010: 6 publications 2011: 12 publications 2012: 7 publications 2013: 21 publications 2014: 34 publications 2015: 34 publications 2016: 46 publications 2017: 38 publications 2018: 28 publications 2019: 17 publications 2020: 18 publications 2021: 16 publications 2022: 11 publications 2023: 40 publications 2024: 19 publications 2025: 36 publications
1991 2025

506 publications in total across all disciplines

View publications per year as a table
Howard L. Kaufman: publications per year, 1991 to 2025
Year Publications
1991 1
1992 2
1993 2
1994 0
1995 0
1996 4
1997 1
1998 2
1999 3
2000 8
2001 5
2002 9
2003 8
2004 20
2005 13
2006 14
2007 13
2008 10
2009 8
2010 6
2011 12
2012 7
2013 21
2014 34
2015 34
2016 46
2017 38
2018 28
2019 17
2020 18
2021 16
2022 11
2023 40
2024 19
2025 36
Total 506
Download as CSV

Howard L. Kaufman publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Howard L. Kaufman sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 402–411 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 411 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54 411
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Howard L. Kaufman D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Howard L. Kaufman sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 84–85 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 85 D-Index — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121 85
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Howard L. Kaufman is affiliated with Harvard University in the United States. Their research primarily focuses on Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions to Oncology, Immunology, Genetics, Molecular Biology, and Epidemiology.

Their scholarly work spans several key topics within biomedical research, including:

  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses
  • Cancer Immunotherapy and Biomarkers
  • Virus-based gene therapy research
  • Nonmelanoma Skin Cancer Studies
  • Cutaneous Melanoma Detection and Management
  • Viral Infectious Diseases and Gene Expression in Insects

Among their recent publications are:

  • Therapy with oncolytic viruses: progress and challenges, 2023, Nature Reviews Clinical Oncology
  • Clinical landscape of oncolytic virus research in 2020, 2020, Journal for ImmunoTherapy of Cancer
  • Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma, 2022, New England Journal of Medicine
  • Immunotherapy for Non-melanoma Skin Cancer, 2021, Current Oncology Reports
  • Advanced bioinformatics rapidly identifies existing therapeutics for patients with coronavirus disease-2019 (COVID-19), 2020, Journal of Translational Medicine

They frequently collaborate with other researchers. Their notable co-authors include:

  • David M. Miller (23 collaborations)
  • Kevin S. Emerick (20 collaborations)
  • Sophia Z. Shalhout (19 collaborations)
  • Sailaja Battula (15 collaborations)
  • Ann W. Silk (11 collaborations)

Kaufman's publications often appear in specific venues with repeated contributions. The most frequent publication venues are:

  • Regular and Young Investigator Award Abstracts (14 publications)
  • Journal for ImmunoTherapy of Cancer (10 publications)
  • Journal of Cutaneous Oncology (9 publications)
  • Journal of Clinical Oncology (6 publications)
  • Cancer Research (5 publications)

Best Publications

  • Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

    Robert H.I. Andtbacka;Howard L. Kaufman;Frances Collichio;Thomas Amatruda

  • Managing toxicities associated with immune checkpoint inhibitors: Consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group

    I. Puzanov;A. Diab;K. Abdallah;C. O. Bingham

  • Oncolytic viruses: a new class of immunotherapy drugs

    Howard L. Kaufman;Frederick J. Kohlhapp;Andrew Zloza

  • Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial

    Howard L. Kaufman;Jeffery Russell;Omid Hamid;Shailender Bhatia

  • gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma.

    Douglas J. Schwartzentruber;David H. Lawson;Jon M. Richards;Robert M. Conry

  • Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

    Lorenzo Galluzzi;Ilio Vitale;Sarah Warren;Sandy Adjemian

  • Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma

    Neil N. Senzer;Howard L. Kaufman;Thomas Amatruda;Mike Nemunaitis

  • Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma

    Jason Chesney;Igor Puzanov;Frances Collichio;Parminder Singh

  • Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders

    Douglas B. Johnson;Ryan J. Sullivan;Patrick A. Ott;Matteo S. Carlino

  • Integrating oncolytic viruses in combination cancer immunotherapy

    Praveen K. Bommareddy;Megha Shettigar;Howard L. Kaufman

  • Local and distant immunity induced by intralesional vaccination with an oncolytic herpes virus encoding GM-CSF in patients with stage IIIc and IV melanoma.

    Howard L. Kaufman;Dae Won Kim;Gail DeRaffele;Josephine Mitcham

  • Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma

    Igor Puzanov;Mohammed M. Milhem;David Minor;Omid Hamid

  • Therapy with oncolytic viruses: progress and challenges

    Unknown

  • Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III–IV melanoma

    Robert H. I. Andtbacka;Frances Collichio;Kevin J. Harrington;Mark R. Middleton

  • Comparison of RNA-seq and microarray-based models for clinical endpoint prediction.

    Wenqian Zhang;Ying Yu;Falk Hertwig;Falk Hertwig;Jean Thierry-Mieg

  • Characterization of CD4+CD25+ Regulatory T Cells in Patients Treated With High-Dose Interleukin-2 for Metastatic Melanoma or Renal Cell Carcinoma

    Giovanni C. Cesana;Gail DeRaffele;Seth Cohen;Dorota Moroziewicz

  • Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer

    Janice M. Mehnert;Anshuman Panda;Hua Zhong;Hua Zhong;Kim Hirshfield

  • Combination immunotherapy: a road map

    Patrick A. Ott;F. Stephen Hodi;Howard L. Kaufman;Jon M. Wigginton

  • Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma: A Preplanned Interim Analysis of a Clinical Trial

    Sandra P. D’Angelo;Jeffery Russell;Céleste Lebbé;Bartosz Chmielowski

  • Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy.

    Hasan Rehman;Ann W. Silk;Michael P. Kane;Howard L. Kaufman

  • Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule.

    Heidi Hörig;David S. Lee;William Conkright;Joe Divito

Frequent Co-Authors

David F. McDermott
David F. McDermott Beth Israel Deaconess Medical Center
Michael A. Morse
Michael A. Morse Duke University
Igor Puzanov
Igor Puzanov Roswell Park Cancer Institute
John Nemunaitis
John Nemunaitis Gradalis (United States)
Kevin J. Harrington
Kevin J. Harrington Royal Marsden NHS Foundation Trust
Merrick I. Ross
Merrick I. Ross The University of Texas MD Anderson Cancer Center
Omid Hamid
Omid Hamid Cedars-Sinai Medical Center
F. Stephen Hodi
F. Stephen Hodi Harvard University
Lisa H. Butterfield
Lisa H. Butterfield University of California, San Francisco
Jeffrey Schlom
Jeffrey Schlom National Institutes of Health

External Links

Personal website of Howard L. Kaufman

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related healthcare degrees can open diverse career opportunities. Many students start with foundational nursing programs, such as online ABSN programs for non nurses. These accelerated courses are designed for individuals transitioning into nursing from other fields, providing a fast but thorough route into patient care and clinical practice.

When considering accelerated options, it’s important to understand that some come with more accessible admissions criteria. Resources highlighting the easiest accelerated nursing programs can help applicants identify programs that balance rigor with attainable entry requirements.

Beginning a nursing career might also involve enrolling in programs with simpler acceptance processes. For example, LPN schools easy to get into offer practical and practical nursing training that can serve as a stepping stone to advanced degrees in healthcare and immunology research.

Advancing further, some pursue specialized roles through nurse practitioner degrees. Exploring the what is the easiest NP program resources allows students to find programs that offer manageable entry into this expert level of nursing, which often intersects with immunology in clinical and research settings.

Best Scientists Citing Howard L. Kaufman

Jeffrey Schlom

Jeffrey Schlom

National Institutes of Health

Publications: 113

James L. Gulley

James L. Gulley

National Institutes of Health

Publications: 88

John C. Bell

John C. Bell

University of Ottawa

Publications: 76

Francesco M. Marincola

Francesco M. Marincola

National Institutes of Health

Publications: 66

Lorenzo Galluzzi

Lorenzo Galluzzi

Cornell University

Publications: 61

Paolo A. Ascierto

Paolo A. Ascierto

National Institutes of Health

Publications: 59

Guido Kroemer

Guido Kroemer

Université Paris Cité

Publications: 55

James W. Hodge

James W. Hodge

National Institutes of Health

Publications: 55

Dirk Schadendorf

Dirk Schadendorf

University of Duisburg-Essen

Publications: 51

Douglas B. Johnson

Douglas B. Johnson

Vanderbilt University Medical Center

Publications: 51

Jedd D. Wolchok

Jedd D. Wolchok

Cornell University

Publications: 50

Laurence Zitvogel

Laurence Zitvogel

University of Paris-Saclay

Publications: 49

Akseli Hemminki

Akseli Hemminki

University of Helsinki

Publications: 49

Philip M. Arlen

Philip M. Arlen

National Institutes of Health

Publications: 47

Aurélien Marabelle

Aurélien Marabelle

Institut Gustave Roussy

Publications: 46

Kevin J. Harrington

Kevin J. Harrington

Royal Marsden NHS Foundation Trust

Publications: 46

Trending Scientists

Liang Fang

Liang Fang

Chongqing University

Kevin Kendall

Kevin Kendall

Hydrogen United

Martyn L. Gorman

Martyn L. Gorman

University of Aberdeen

Fritz Strack

Fritz Strack

University of Würzburg

Brenda Rapp

Brenda Rapp

Johns Hopkins University

Antonio Piralla

Antonio Piralla

Policlinico San Matteo Fondazione

Gerald D. Fischbach

Gerald D. Fischbach

Columbia University

João Ramalho-Santos

João Ramalho-Santos

University of Coimbra

Aleksander Hinek

Aleksander Hinek

University of Toronto

Randall T. Peterson

Randall T. Peterson

University of Utah

Gabriele Bammer

Gabriele Bammer

Australian National University

William D'haeseleer

William D'haeseleer

KU Leuven

David Lo

David Lo

Singapore Management University

Daniel M. Dias

Daniel M. Dias

IBM (United States)

Salman Khan

Salman Khan

Mohamed bin Zayed University of Artificial Intelligence

Timothy B. Johnson

Timothy B. Johnson

Ministry of Natural Resources and Forestry

Related Immunology Rankings & Guides

2027 Best LVN Programs in Texas – Accredited Online LPN Programs

2027 Best LVN Programs in Texas – Accredited Online LPN Programs
2027 Best LPN Programs in North Carolina – Accredited Online LPN Programs

2027 Best LPN Programs in North Carolina – Accredited Online LPN Programs
2027 Best Accelerated Paramedic to RN Online Bridge Programs

2027 Best Accelerated Paramedic to RN Online Bridge Programs
2027 Best ABSN Programs - Accelerated BSN Programs in Missouri: Online & Campus

2027 Best ABSN Programs - Accelerated BSN Programs in Missouri: Online & Campus
2027 Best CNA to RN Degree Online Bridge Programs

2027 Best CNA to RN Degree Online Bridge Programs
2027 Best Accelerated Online Bachelor's in Health Sciences Programs

2027 Best Accelerated Online Bachelor's in Health Sciences Programs
2027 Best Medical Assistant Classes Online with Financial Aid

2027 Best Medical Assistant Classes Online with Financial Aid
2027 Best LPN Programs in New Jersey – Accredited Online LPN Programs

2027 Best LPN Programs in New Jersey – Accredited Online LPN Programs
2027 Best Accelerated Online Master’s Programs in Nutrition

2027 Best Accelerated Online Master’s Programs in Nutrition
2027 Best 12-month Accelerated Online Nursing Degree Programs

2027 Best 12-month Accelerated Online Nursing Degree Programs
Best Direct-Entry MSN Programs in Texas: Online & Campus for 2027

Best Direct-Entry MSN Programs in Texas: Online & Campus for 2027
2027 Best LPN Programs in Utah – Accredited Online LPN Programs

2027 Best LPN Programs in Utah – Accredited Online LPN Programs
2027 Best Medical Assistant to LPN Programs Online

2027 Best Medical Assistant to LPN Programs Online
2027 Best MRI Technician Programs

2027 Best MRI Technician Programs
2027 Best HBCU Nursing Programs

2027 Best HBCU Nursing Programs
2027 Best Accelerated Online Nurse Executive Leadership MSN Programs

2027 Best Accelerated Online Nurse Executive Leadership MSN Programs
2027 Best LPN Programs in Florida – Accredited Online LPN Programs

2027 Best LPN Programs in Florida – Accredited Online LPN Programs
2027 Become a Medical Assistant in 6 Weeks – Best Accelerated Programs

2027 Become a Medical Assistant in 6 Weeks – Best Accelerated Programs
2027 Best 1-Year Master's In Healthcare Administration

2027 Best 1-Year Master's In Healthcare Administration
2027 ADN vs. AAD vs. AAS Nursing Degree Programs: Explaining The Difference

2027 ADN vs. AAD vs. AAS Nursing Degree Programs: Explaining The Difference
September 2027 Best 4-Week Online Course for Medical Coding and Billing

September 2027 Best 4-Week Online Course for Medical Coding and Billing

Recently Published Articles

2027 Cheapest and Shortest Online Urban Planning Degree Programs That Pay Well: Cost, Duration, and Salary Outlook

2027 Cheapest and Shortest Online Urban Planning Degree Programs That Pay Well: Cost, Duration, and Salary Outlook
2027 Online Cybersecurity Bachelor's Degree Programs With Open Enrollment

2027 Online Cybersecurity Bachelor's Degree Programs With Open Enrollment
2027 One-Year Online Industrial Organizational Psychology Master's Degree Programs: Accelerated Options, Costs & Outcomes

2027 One-Year Online Industrial Organizational Psychology Master's Degree Programs: Accelerated Options, Costs & Outcomes
2027 How to Become a High School History Teacher in Iowa: Requirements & Certification

2027 How to Become a High School History Teacher in Iowa: Requirements & Certification
2027 Easiest Online Clinical Mental Health Counseling Master's Degree Programs That Pay Well: High-Salary Degrees with Simple Admissions

2027 Easiest Online Clinical Mental Health Counseling Master's Degree Programs That Pay Well: High-Salary Degrees with Simple Admissions
2027 How to Verify Accreditation for Information Technology Degree Programs

2027 How to Verify Accreditation for Information Technology Degree Programs
2027 How to Become an Elementary School Teacher in Missouri: Requirements & Certification

2027 How to Become an Elementary School Teacher in Missouri: Requirements & Certification
2027 Are There Any One-Year Online Business Law Degree Programs Worth Considering?

2027 Are There Any One-Year Online Business Law Degree Programs Worth Considering?
2027 Online Nutrition Degree Programs With No Personal Statement or Admissions Essay Required

2027 Online Nutrition Degree Programs With No Personal Statement or Admissions Essay Required
2027 Are Too Many Students Choosing Interdisciplinary Studies? Oversaturation, Competition, and Hiring Reality

2027 Are Too Many Students Choosing Interdisciplinary Studies? Oversaturation, Competition, and Hiring Reality
2027 Different Types of Applied Business & Technology Degrees and Their Salaries

2027 Different Types of Applied Business & Technology Degrees and Their Salaries
2027 Most Affordable Online MBA in Information Technology Degree Programs

2027 Most Affordable Online MBA in Information Technology Degree Programs
2027 What Degree Do You Need to Be a Social Worker: Education Requirements in Louisiana

2027 What Degree Do You Need to Be a Social Worker: Education Requirements in Louisiana
2027 Walden University Online MS in Psychology - Applied Behavior Analysis: Cost, Curriculum, Admissions, and Career Outcomes

2027 Walden University Online MS in Psychology - Applied Behavior Analysis: Cost, Curriculum, Admissions, and Career Outcomes
2027 Best Online MBA in Project Management Programs

2027 Best Online MBA in Project Management Programs
2027 Is a Leadership Master's Degree Worth It? ROI, Salary & Career Impact

2027 Is a Leadership Master's Degree Worth It? ROI, Salary & Career Impact
2027 Maine Psychology Licensure Requirements – How to Become a Psychologist in Maine

2027 Maine Psychology Licensure Requirements – How to Become a Psychologist in Maine
2027 Best Online Medical Coding Training Programs: Guide to Online Courses

2027 Best Online Medical Coding Training Programs: Guide to Online Courses
2027 Best HBCU Online Degree Programs

2027 Best HBCU Online Degree Programs
2027 Best Medical Assistant Schools & Programs in Tennessee – How to Become a Medical Assistant in Tennessee

2027 Best Medical Assistant Schools & Programs in Tennessee – How to Become a Medical Assistant in Tennessee
2027 How to Become an Art Teacher in Illinois: Requirements & Certification

2027 How to Become an Art Teacher in Illinois: Requirements & Certification